Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{O'Brien:2012,
author = {O'Brien, M and Gaafar, RM and Popat, S and Grossi, F and Price, A and Talbot, DC and Cufer, T and Ottensmeier, CHH and Danson, S and Pallis, AG and Hasan, B and Van, Meerbeeck JP and Baas, P},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803386&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2012}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - O'Brien,M
AU - Gaafar,RM
AU - Popat,S
AU - Grossi,F
AU - Price,A
AU - Talbot,DC
AU - Cufer,T
AU - Ottensmeier,CHH
AU - Danson,S
AU - Pallis,AG
AU - Hasan,B
AU - Van,Meerbeeck JP
AU - Baas,P
PB - AMER SOC CLINICAL ONCOLOGY
PY - 2012///
SN - 0732-183X
TI - Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803386&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -